These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25624454)

  • 1. PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism.
    McKay JT; Egan RP; Yammani RD; Chen L; Shin T; Yagita H; Haas KM
    J Immunol; 2015 Mar; 194(5):2289-99. PubMed ID: 25624454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 3. SLy2 controls the antibody response to pneumococcal vaccine through an IL-5Rα-dependent mechanism in B-1 cells.
    Schmitt F; Schäll D; Bucher K; Schindler TI; Hector A; Biedermann T; Zemlin M; Hartl D; Beer-Hammer S
    Eur J Immunol; 2015 Jan; 45(1):60-70. PubMed ID: 25330943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
    Spurrier MA; Jennings-Gee JE; Daly CA; Haas KM
    J Immunol; 2021 Oct; 207(8):1978-1989. PubMed ID: 34535576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.
    Haas KM; Poe JC; Tedder TF
    J Immunol; 2009 Sep; 183(6):3661-71. PubMed ID: 19710450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
    Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with Recombinant Pneumolysin Induces the Production of Antibodies and Protects Mice in a Model of Systemic Infection Caused by Streptococcus pneumoniae.
    Petukhova ES; Vorobyev DS; Sidorov AV; Semenova IB; Volokh YV; Leonova AY; Sidorova AV; Mikhailova NA
    Bull Exp Biol Med; 2020 Feb; 168(4):485-487. PubMed ID: 32146631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
    Khan AQ; Lees A; Snapper CM
    J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae.
    Shriner AK; Liu H; Sun G; Guimond M; Alugupalli KR
    J Immunol; 2010 Jul; 185(1):525-31. PubMed ID: 20505146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Regulatory T Cell Immune Response Induced by Intranasal Immunization With the Live-Attenuated Pneumococcal Vaccine SPY1
    Liao H; Peng X; Gan L; Feng J; Gao Y; Yang S; Hu X; Zhang L; Yin Y; Wang H; Xu X
    Front Immunol; 2018; 9():1754. PubMed ID: 30116243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses.
    Wilson R; Cohen JM; Jose RJ; de Vogel C; Baxendale H; Brown JS
    Mucosal Immunol; 2015 May; 8(3):627-39. PubMed ID: 25354319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
    Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
    Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of cross-activity of Streptococcus pneumoniae antigen preparations].
    Vaneeva NP; Vorob'ev DS; Grishchenko NV; Kurbatova EA; Iastrebova NE; Kalina NG; Elkina SI; Zubkov AV; Aparin PG; L'vov VL; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):36-42. PubMed ID: 23163034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.